Impact of Probiotics in Human Health and Disease Treatment

Probiotics have become the major breakthrough in therapeutic applications due to their various health promoting effects in humans by maintaining the homeostasis of the intestine and prevent microbial imbalance (dysbiosis) without any side effects. Dysbiosis in the microbial population is the major cause for several diseases in humans. Treatment of diseases using antibiotics is not recommended due to high cost, side effects, and the loss of intestinal friendly bacteria. Probiotics work in symbiotic association with the intestine and produce several metabolites which not only regulate the growth of pathogenic bacteria but also provide vital nutrients which contribute to human health. The present chapter highlights about the role of probiotics in treatment and prevention of different human diseases.

• Publication year

  2019

• Venue

  Nutraceutical and Functional Foods in Disease Prevention

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4018/978-1-5225-3267-5.CH002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The gut microbiota and psychiatric illness.

  2017cited by this paper
• More Than a Gut Feeling: The Implications of the Gut Microbiota in Psychiatry.

  2017cited by this paper
• Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health

  2016cited by this paper
• Abundance and Diversity of Denitrifying and Anammox Bacteria in Seasonally Hypoxic and Sulfidic Sediments of the Saline Lake Grevelingen

  2016cited by this paper
• The gut microbiome, diet, and links to cardiometabolic and chronic disorders

  2016cited by this paper
• The gut microbiota: A treasure for human health.

  2016cited by this paper
• Non-dairy Based Probiotics: A Healthy Treat for Intestine

  2016cited by this paper
• The 12 Gastrointestinal Pathogens Spectrum of Acute Infectious Diarrhea in a Sentinel Hospital, Shenzhen, China

  2016cited by this paper
• Role of Probiotics in human health and disease: An update

  2016cited by this paper
• Can probiotics benefit children with autism spectrum disorders?

  2016cited by this paper
• Are probiotics useful in Helicobacter pylori eradication?

  2015cited by this paper
• The gut microbiome in cardio-metabolic health

  2015cited by this paper
• Probiotics: an update.

  2015cited by this paper
• Probiotics, prebiotics and synbiotics- a review

  2015cited by this paper
• Gut microbiota and liver diseases.

  2015cited by this paper
• The gut microbiota and host health: a new clinical frontier

  2015cited by this paper
• The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• Trends in dairy and non-dairy probiotic products - a review

  2015cited by this paper
• Probiotics and chronic kidney disease.

  2015cited by this paper
• Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment

  2015cited by this paper
• Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects

  2015cited by this paper
• Far from the Eyes, Close to the Heart: Dysbiosis of Gut Microbiota and Cardiovascular Consequences

  2014cited by this paper
• The role of microbiome in central nervous system disorders.

  2014cited by this paper
• Gut microbiota, probiotics and diabetes

  2014cited by this paper
• The SCFA Receptor GPR43 and Energy Metabolism

  2014cited by this paper
• The gut microbiota and inflammatory bowel disease

  2014cited by this paper
• Impact of Probiotics on Risk Factors for Cardiovascular Diseases. A Review

  2014cited by this paper
• Probiotic functional foods: Survival of probiotics during processing and storage

  2014cited by this paper
• Farmers’ market use is associated with fruit and vegetable consumption in diverse southern rural communities

  2014cited by this paper
• Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

  2014cited by this paper
• Selection of uremic toxin-reducing probiotics in vitro and in vivo

  2014cited by this paper
• Role of Probiotics in health improvement, infection control and disease treatment and management

  2013cited by this paper
• Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion*

  2013cited by this paper
• Somatostatin Analogs Therapy in Gastroenteropancreatic Neuroendocrine Tumors: Current Aspects and New Perspectives

  2013cited by this paper
• Probiotics in human health

  2013cited by this paper
• Non-dairy probiotic beverages: the next step into human health.

  2013cited by this paper
• An update on the use and investigation of probiotics in health and disease

  2013cited by this paper
• Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders.

  2013cited by this paper
• Health Benefits of Probiotics: A Review

  2013cited by this paper
• Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective

  2013cited by this paper
• The oral microbiome in health and disease.

  2013cited by this paper
• Mechanism of action of probiotics

  2013cited by this paper
• Probiotics for the Treatment of Inflammatory Bowel Disease

  2012cited by this paper
• Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

  2012cited by this paper
• Probiotic Mechanisms of Action

  2012cited by this paper
• Probiotic Fermentation of Plant Based Products: Possibilities and Opportunities

  2012cited by this paper
• Lactic acid bacteria producing B-group vitamins: a great potential for functional cereals products

  2012cited by this paper
• The inflammasome puts obesity in the danger zone.

  2012cited by this paper
• Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa

  2011cited by this paper
• Enterococci as probiotics and their implications in food safety.

  2011cited by this paper
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.

  2011cited by this paper
• Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life –– a double‐blind, placebo‐controlled study

  2011cited by this paper
• A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

  2011cited by this paper
• Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects

  2011cited by this paper
• An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota

  2011cited by this paper
• Lactic acid bacteria in traditional fermented Chinese foods

  2011cited by this paper
• Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

  2011cited by this paper
• Screening selected strains of probiotic lactic acid bacteria for their ability to produce biogenic amines (histamine and tyramine)

  2011cited by this paper
• A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders.

  2010cited by this paper
• Risk indicators for severe impaired oral health among indigenous Australian young adults

  2010cited by this paper
• Intake of Lactobacillus plantarum Reduces Certain Gastrointestinal Symptoms During Treatment With Antibiotics

  2010cited by this paper
• Safety assessment of probiotics for human use

  2010cited by this paper
• Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro study

  2010cited by this paper
• Probiotics and the gut microbiota in intestinal health and disease

  2010cited by this paper
• Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

  2010cited by this paper
• Probiotic therapy for irritable bowel syndrome.

  2010cited by this paper
• Probiotic Dairy Products as Functional Foods.

  2010cited by this paper
• Uremic toxins originating from colonic microbial metabolism.

  2009cited by this paper
• Characterization and purification of a new bacteriocin with a broad inhibitory spectrum produced by Lactobacillus plantarum lp 31 strain isolated from dry‐fermented sausage

  2009cited by this paper
• Probiotics and gastrointestinal disease: successes, problems and future prospects

  2009cited by this paper
• Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth

  2009cited by this paper
• Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells.

  2009cited by this paper
• Antibiotic-associated diarrhea: epidemiology, trends and treatment.

  2008cited by this paper
• Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.

  2008cited by this paper
• Probiotics Reduce the Prevalence of Oral Candida in the Elderly—a Randomized Controlled Trial

  2007cited by this paper
• Helicobacter pylori and probiotics.

  2007cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

  2005cited by this paper
• Antibiotic-associated diarrhoea

  2004cited by this paper
• The Composition of the Microflora of Boza, an Original Bulgarian Beverage

  2003cited by this paper
• Clinical practice. Antibiotic-associated diarrhea.

  2002cited by this paper
• Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

  2001cited by this paper
• Phenotypically based taxonomy using API 50CH of lactobacilli from Nigerian ogi, and the occurrence of starch fermenting strains.

  1995cited by this paper

• Ethnic foods: impact of probiotics on human health and disease treatment

  2024cites this paper
• Probiotic beverages in India: History and current developments

  2021cites this paper
• In Vitro Detoxification Studies of p-Cresol by Intestinal Bacteria Isolated from Human Feces

  2020cites this paper